Why should we still care about the stavudine dose?

Current recommendations advise that stavudine be phased out of use. The logistics and cost of switching are significant, and the World Health Organization has forecast that 1.55 million people will still be on stavudine-based antiretroviral therapy by the end of 2012. Stavudine is co-formulated in m...

Full description

Bibliographic Details
Main Authors: Steve Innes, Mark Cotton, Francois Venter
Format: Article
Published: AOSIS 2011-12-01
Series:Southern African Journal of HIV Medicine
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/166